A quantitative analysis of the prevalence of clinical depression and anxiety in patients with prostate cancer undergoing active surveillance.

Objective: To quantitatively determine the prevalence of anxiety and depression in men on active surveillance (AS).

Design: Cross-sectional questionnaire survey.

Setting: Secondary care prostate cancer (PCa) clinics across South, Central and Western England.